Nalena Review
No longer offers GLP-1s — the brand now sells an ED treatmentNalena scores highest on state availability and ease of access.
Nalena: No longer offers GLP-1s — the brand now sells an ED treatment. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
See our top-rated GLP-1 providers →Nalena is a women-focused, GLP-1-only telehealth platform offering compounded semaglutide and tirzepatide with medication included — no separate membership or visit fees. Its positioning leans on transparency: no hidden fees, cancel anytime, and a money-back guarantee uncommon among compounded providers. Pricing starts at $149/month with no insurance required and free 2-day shipping; clinical care is delivered by Beluga Health, P.A.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Nalena
Editorial score · methodology
altRX
Best for: the only platform offering all four brand-name GLP-1s plus compounded
Editorial score · methodology
RxSpan MD
Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
Editorial score · methodology
Nalena at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Nalena
Each dimension is scored algorithmically from Nalena’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.8/10Nalena does not post a standard monthly cash price up front, so cost transparency is limited — confirm the ongoing rate before you commit.
Effectiveness25%
8.6/10Nalena offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.9/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
8.5/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.
Accessibility10%
8.8/10Nalena treats patients in all 50 states.
Support10%
6.4/10Nalena provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Nalena review
Last checked August 2026- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Nalena
We walked Nalena’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete an online assessment covering your symptoms, medical history, and wellness goals.
- 2A licensed clinician reviews your information and develops a personalized treatment plan.
- 3If appropriate, a GLP-1 medication is prescribed.
- 4Medication is shipped directly to your home with ongoing support.
- GLP-1 weight-loss telehealth positioned specifically for women navigating hormonal shifts (perimenopause, menopause, postmenopause).
- Offers semaglutide (advertised at $299/month) and tirzepatide (advertised at $399/month), each with a stated $120 discount on the first month.
- Available in all 50 states with medication shipped to the home.
- States it holds LegitScript certification.
- Launched February 2026; care is delivered entirely online.
GLP-1 medications Nalena offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
What we like
- Compounded GLP-1 from $149/mo with medication included — near the floor of the compounded market
- Transparent fee model: no hidden fees, no membership, cancel anytime
- Money-back guarantee — uncommon among compounded telehealths
- Clinical provider disclosed: Beluga Health, P.A. in Houston, TX
- Women-focused positioning
- Free 2-day shipping
- Both compounded semaglutide and tirzepatide offered
Watch-outs
- Per-dose pricing not published — only the 'starting at $149' entry price
- No LegitScript, HIPAA, or NABP badges on public pages
- Compounding pharmacy partners not named (only 'multiple USA certified pharmacies')
- Houston address looks like a virtual office rather than a clinical facility
- No brand-name GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro) — compounded only
- Women-focused framing may under-serve male patients
- Texas patients may face licensure friction since Beluga Health is incorporated in Florida
Nalena no longer does weight loss — it is now an ED brand
If you came here for Nalena's compounded GLP-1 program for women, it is gone. Until mid-2026 Nalena did one narrow thing well: it bundled compounded semaglutide or tirzepatide with the consult and shipping into a single all-in monthly price, with no membership and no separate visit fee. As of August 2026, none of that is left. The homepage now reads "Nalena × VIGO MD · Sister telehealth brands, one physician network" and sells a single erectile-dysfunction product, a physician-prescribed sublingual tablet billed monthly.
This is not a judgment call about emphasis. Across the whole homepage the words semaglutide, tirzepatide, GLP-1 and weight appear exactly zero times — not in the navigation, not in the treatments section, not in the FAQ. A weight-loss service does not describe itself without ever using the word weight. The one price on the page belongs to that ED tablet.
What to do if you were a patient
There is no published route on the site to refill a GLP-1 prescription or reach the clinician who wrote it; support is a single email address. If you were mid-treatment, the priority is continuing care somewhere else rather than stopping abruptly — a GLP-1 dose should be continued or tapered on clinical advice, not interrupted because a provider changed its business. Ask your new provider to request your records, and if you have a pharmacy name on an old label, contact that pharmacy directly, since the dispensing pharmacy is a separate business from the brand that arranged the visit.
Why this page is still here
"Is Nalena still around?" is a reasonable thing to search, and a straight answer beats a dead link or a review describing a service you can no longer buy. The honest answer is that the company still exists and the weight-loss program does not. Nalena is excluded from every WLR ranking and best-of list, carries no outbound link, and the alternatives shown on this page are all currently operating and were price-checked recently. When you compare them, look at what each bundles as well as what it charges. An all-in rate like the one Nalena used to offer is worth more than a lower headline that adds the consult, the shipping or the dose increase back on at checkout. Our scoring methodology explains how we weigh those inclusions.
For a side-by-side, Collective ($59/month) is a comparable option to weigh against Nalena.
The Bottom Line
Nalena scores highest on state availability and ease of access.
Nalena might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Nalena review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.